Registrations now open for MVEC’s Immunisation Skills Workshop – Friday 25 November 2022

MVEC are pleased to announce that registrations for our Immunisation Skills Workshop taking place on Friday 25th November are now open.  

The full day interactive, face to face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing: 

  • effective vaccine communication 
  • error prevention and management 
  • anaphylaxis and acute stress responses. 

Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios. 

The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time). 

Venue: The HELP Precinct, The Royal Children’s Hospital, 50 Flemington Road, Parkville
Time: 8:30am – 4:30pm
Cost: $290.00 (including catering) 

Register for the Immunisation Skills Workshop now via the link below!
MVEC Immunisation Skills Workshop 


New immunisation reference page – Monkeypox

Monkeypox is a viral zoonosis (an infection spread from animals to humans). It is caused by a virus that belongs to the Orthopoxvirus genus (which also causes the variola virus responsible for smallpox disease and the vaccinia virus, which is used in smallpox vaccines). Since the eradication of smallpox in 1980, monkeypox has become the most important orthopoxvirus affecting humans, however, causes less severe disease than smallpox.  

The incubation period of monkeypox is usually 7-14 days, with initial symptoms of monkeypox including fever, headache, backache and muscle aches, fatigue and lymphadenopathy. Historically, smallpox vaccines have been used in the prevention of smallpox infection, however, they are also likely to be effective against monkeypox.  

There are two types of smallpox vaccines registered for use in Australia for the prevention of monkeypox, ACAM2000™ and JYNNEOS®.  

Our new reference page outlines symptoms, transmission routes, epidemiology, current vaccine recommendations and links to the latest resources. 

For further information, click on the link below:
MVEC: Monkeypox


MVEC's Immunisation skills workshop - New date announced

Due to increasing COVID-19 case numbers in Victoria and the implementation of visitor restrictions at the Royal Children’s Hospital (RCH), our Immunisation Skills Workshop due to be held at RCH on September 2, has been rescheduled for Friday 25th November. We look forward to announcing the program details and opening the registration for this event in the coming weeks.


Save the date for MVEC’s Immunisation Skills Workshop – Friday 2 September 2022

MVEC are pleased to invite you to save the date for our Immunisation Skills Workshop taking place on Friday 2nd September. 

The full day interactive, face-to-face workshop is MVEC’s newest learning opportunity designed to provide education and upskilling in the principles and processes of managing: 

  • effective vaccine communication 
  • error prevention and management 
  • anaphylaxis and acute stress responses 

Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios. 

The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time). 

Further program details and a link to register will be available via our events page soon. 


A recording of the 28th April CVU mini is now available

Thank you to all who attended our recent CVU miniseries event Winter preparedness: COVID-19 and influenza on Thursday 28th April 2022.

This interactive webinar covered the following updates:

  • COVID-19 vaccines: keeping up-to-date
  • Winter COVID-19 booster dose and flu administration for the elderly
  • Influenza: a post COVID-19 landscape

A recording of this event is now available via our education portal.

To access this recording please follow the link below:

CVU mini - 28th April 2022


Science: Pandemic propels global effort to study rare vaccine side effects

The Global Vaccine Data Network (GVDN) is the largest ever vaccine safety project involving more than 20 countries and data from more than 250 million people vaccinated against COVID-19.

It aims to investigate and understand rare vaccine side effects such as myocarditis, thrombosis with thrombocytopenia syndrome and Guillain-Barre Syndrome following COVID-19 vaccination which may lead to the prediction, treatment and prevention of side effects.

The following article discusses the importance of globalising vaccine safety research through international collaboration to improve vaccine safety.

To read more, please click on the link below.

Science: Pandemic propels global effort to study rare vaccine side effects

 

 

 

 

 

 


Registrations now open for the April CVU mini event

MVEC's first Clinical Vaccinology Update (CVU) miniseries event of the year on Winter preparedness: COVID-19 and influenza will be held virtually on Thursday 28th April 2022. This CVU mini will provide an update on:

  • COVID-19 vaccines: keeping up-to-date
  • Winter COVID-19 booster dose and flu administration for the elderly
  • Influenza: a post COVID-19 landscape

Further details can be found via our Events page and the link below:

CVU mini: April 28th 2022


Save the date for our first CVU mini event for 2022: Thursday 28 April 2022

MVEC invites you to Save the Date for first CVU mini for 2022!

Date: Thursday 28 April, 2022
Time: 7:00pm – 8:30pm AEST

Further details and registration information will be available soon on our Events page and Education Portal.

To keep up to date with our latest news, including upcoming events, you can subscribe to our weekly newsletter.


New reference page: Japanese encephalitis 

An outbreak of Japanese encephalitis virus (JEV), a rare but potentially lethal mosquito-transmitted disease that can cause inflammation of the brain has been detected in Queensland, New South Wales, Victoria and South Australia. While most infections are asymptomatic, it is currently the leading cause of vaccine-preventable encephalitis in Asia.

Our new reference page: Japanese encephalitis addresses key factors including:
- What is JEV?
- What to look for?
- How it is transmitted?
- Epidemiological information
- Prevention
- Vaccine information

Follow the link to view the full reference page:
Japanese encephalitis


NCIRS Webinar - Living with COVID-19: Getting back to immunisation business as usual

NCIRS will be hosting a webinar on Thursday 3 March featuring a panel of expert speakers including MVEC’s A/Prof Nigel Crawford. The topic for the webinar is Living with COVID-19: Getting back to immunisation business as usual and will cover: 

  • an update on Australian COVID‑19 vaccine recommendations 
  • COVID-19 and routine immunisation programs regionally and globally – what’s needed 
  • new COVID-19 vaccines – do we need to change our strategy in response to new variants? 

Further information and details on registration can be found via the link below:
NCIRS Webinar -  Living with COVID-19: Getting back to immunisation business as usual